MCT8 expression in human fetal cerebral cortex is reduced in severe intrauterine growth restriction by Chan, Shiaoyng et al.
 
 
University of Birmingham
MCT8 expression in human fetal cerebral cortex is
reduced in severe intrauterine growth restriction
Chan, Shiaoyng; Hancox, L. A.; Martin-santos, A.; Loubiere, L. S.; Walter, Merlin; Gonzalez,
A.-m.; Cox, Phillip; Logan, A.; Mccabe, C. J.; Franklyn, J. A.; Kilby, M. D.
DOI:
10.1530/JOE-13-0400
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Chan, S, Hancox, LA, Martin-santos, A, Loubiere, LS, Walter, M, Gonzalez, A, Cox, P, Logan, A, Mccabe, CJ,
Franklyn, JA & Kilby, MD 2014, 'MCT8 expression in human fetal cerebral cortex is reduced in severe
intrauterine growth restriction', Journal of Endocrinology, vol. 220, no. 2, pp. 85-95. https://doi.org/10.1530/JOE-
13-0400
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
 2014 The authors
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Jo
u
rn
a
l
o
f
E
n
d
o
cr
in
o
lo
g
y
Research
Open Access
S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 85–95MCT8 expression in human fetal
cerebral cortex is reduced in severe
intrauterine growth restrictionShiao Y Chan1, Laura A Hancox1, Azucena Martı´n-Santos1, Laurence S Loubie`re1,
Merlin N M Walter1, Ana-Maria Gonza´lez1, Phillip M Cox2, Ann Logan1,
Christopher J McCabe1, Jayne A Franklyn1 and Mark D Kilby1,3
1School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham,
Edgbaston, Birmingham B15 2TT, UK
2Department of Pathology and 3Fetal Medicine Centre, Birmingham Women’s NHS Foundation Trust, Edgbaston,
Birmingham B15 2TG, UKhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Published by Bioscientifica Ltd
Printed in Great Britain
This work is l
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to S Y Chan
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s.chan@bham.ac.ukAbstractThe importance of the thyroid hormone (TH) transporter, monocarboxylate transporter 8
(MCT8), to human neurodevelopment is highlighted by findings of severe global neurological
impairment in subjects with MCT8 (SLC16A2) mutations. Intrauterine growth restriction
(IUGR), usually due to uteroplacental failure, is associated with milder neurodevelopmental
deficits, which have been partly attributed to dysregulated TH action in utero secondary to
reduced circulating fetal TH concentrations and decreased cerebral thyroid hormone receptor
expression. We postulate that altered MCT8 expression is implicated in this pathophysiology;
therefore, in this study, we sought to quantify changes in cortical MCT8 expression with IUGR.
First, MCT8 immunohistochemistry was performed on occipital and parietal cerebral cortex
sections obtained from appropriately grown for gestational age (AGA) human fetuses
between 19 weeks of gestation and term. Secondly, MCT8 immunostaining in the occipital
cortex of stillborn IUGR human fetuses at 24–28 weeks of gestation was objectively compared
with that in the occipital cortex of gestationally matched AGA fetuses. Fetuses demonstrated
widespread MCT8 expression in neurons within the cortical plate and subplate, in the
ventricular and subventricular zones, in the epithelium of the choroid plexus and ependyma,
and in microvessel wall. When complicated by IUGR, fetuses showed a significant fivefold
reduction in the percentage area of cortical plate immunostained for MCT8 compared with
AGA fetuses (P!0.05), but there was no significant difference in the proportion of subplate
microvessels immunostained. Cortical MCT8 expression was negatively correlated with the
severity of IUGR indicated by the brain:liver weight ratios (r2Z0.28; P!0.05) at post-mortem.
Our results support the hypothesis that a reduction in MCT8 expression in the IUGR fetal brain
could further compromise TH-dependent brain development.Key Words
" MCT8
" human fetus
" CNS
" intrauterine growth
restriction (IUGR)icen
.0 UJournal of Endocrinology
(2014) 220, 85–95IntroductionIntrauterine growth restriction (IUGR) describes the fail-
ure of a fetus to attain its genetically determined growth
potential, with the most common underlying etiologybeing uteroplacental failure associated with abnormal
placental development. IUGR is often characterized by
continued head and brain growth at the expense of othersed under a Creative Commons
nported License.
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Research S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 86less vital organs resulting in an elevated brain:liver weight
ratio postnatally (Cox & Marton 2009). IUGR complicates
5–10% of pregnancies and is associated with increased
perinatal mortality (Kady & Gardosi 2004). Survivors
demonstrate an increased prevalence of cognitive impair-
ment compared with babies born appropriately grown for
gestational age (AGA). They have lower school achieve-
ments and intelligence quotient (IQ) scores (Leitner et al.
2007), and 5% show neurodevelopmental delay at the age
of 9–10 years (Kok et al. 1998). Significantly reduced
circulating concentrations of free thyroxine (T4) and
tri-iodothyronine (T3) (Kilby et al. 1998) and decreased
expression of cerebral thyroid hormone receptor (TR)
expression (Kilby et al. 2000) in growth-restricted human
fetuses are postulated to contribute to this neurodevelop-
mental morbidity. Examination of growth-restricted fetal
guinea pigs has shown a compensatory increase in brain
deiodinase type 2 (DIO2) expression, which could increase
local concentrations of the active thyroid hormone (TH)
ligand, T3, from T4 conversion (Chan et al. 2005). In clinical
practice, once IUGR is diagnosed antenatally, timely
delivery aimed at avoiding in utero demise while
prolonging gestation as far as possible for fetal maturity is
the mainstay of management. Currently, there are no
in utero therapies to reduce the risk of neurocognitive
impairment in IUGR. An increased understanding of how
TH-responsive neurodevelopment is altered in IUGR may
lead to the development of novel therapies to improve
long-term outcome.
Monocarboxylate transporter 8 (MCT8) is a highly
specific plasma membrane TH transporter (Friesema et al.
2003). Its importance to human CNS development has
been highlighted by discoveries of different mutations
within the MCT8 gene (SLC16A2) in subjects with a variety
of X-linked mental retardation syndromes, characterized
by severe psychomotor and cognitive impairment and
accompanied by elevated serum free T3 concentrations but
normal or low free T4 concentrations (Dumitrescu et al.
2004, Friesema et al. 2004, Schwartz et al. 2005).
In mice, MCT8 facilitates the entry of TH into the
brain parenchyma across the blood brain–barrier (Ceballos
et al. 2009) and, at a cellular level, the entry of TH into
neurons (Trajkovic et al. 2007), where MCT8 is responsible
for 75% of T3 uptake (Wirth et al. 2009). In rodents, TH
affects cell proliferation and differentiation of neuroblas-
toma cells (Garcia-Silva et al. 2002) and oligodendrocytes
(Jones et al. 2003), neuronal migration (Lavado-Autric
et al. 2003, Auso et al. 2004), synaptogenesis (Gilbert
& Paczkowski 2003), and cerebellar Purkinje cell
dendritic outgrowth (Heuer & Mason 2003). T3 has ahttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Printed in Great Britainproproliferative effect in human neuronal precursor cells,
NT2, but MCT8, independently of T3, could repress NT2
proliferation (James et al. 2009), suggesting another role
for MCT8 apart from TH transport. However, the lack of
neurological defects in Mct8-knockout mice (Wirth et al.
2009) emphasizes the need for studies in humans. From
7 weeks of gestation, the human fetal cerebral cortex
is potentially TH responsive, expressing a range of TH
transporters including MCT8 (Chan et al. 2011) and all
the major TR isoforms (nuclear transcription factors
that bind to T3 to regulate gene transcription), and
demonstrates pre-receptor regulation by DIO2 and deio-
dinase type 3 (DIO3) (which inactivates T4 and T3) (Chan
et al. 2002). Fetal neurons are believed to be the main
target for TH action in the brain.
We hypothesize that human fetal cortical MCT8
expression is reduced with severe IUGR, which could
further compromise neurodevelopment. In this study, we
first carried out localization studies for MCT8 expression
in the human fetal cerebral cortex from mid-gestation
onwards. We then compared cortical MCT8 expression in
severe IUGR human fetuses with that in AGA human
fetuses that were stillborn.Subjects and methods
Brain samples
This study was approved by the South Birmingham
Research Ethics Committee. Written consent for blocks
and slides to be used in research and teaching was
obtained in all cases. Cases were identified retrospectively
from reports of all post-mortems conducted at the
Birmingham Women’s Hospital over a 3-year period.
Only a minority of cases fulfilled our strict inclusion
criteria: normal karyotype, no histopathological evidence
of intrauterine infection, and limited or no maceration
(indicating very short death-to-delivery intervals). Gesta-
tional ages were determined by first-trimester ultrasound
scan for crown–rump length. Sections of formalin-fixed
paraffin-embedded (FFPE) samples were then obtained
from the hospital archive of histopathology blocks.
First, sections of the fetal cerebral cortex (occipital and
parietal) obtained during the second (19–20 weeks; nZ3)
and third (26–37 weeks; nZ3) trimesters from AGA fetuses
with unexplained intrauterine deaths were examined.
Sections of normal adult occipital cortex (one female
aged 55 years and one male aged 37 years) sampled at post-
mortem and donated to the London NeurodegenerativePublished by Bioscientifica Ltd
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Psychiatry) were obtained for comparison.
Secondly, sections of the occipital cerebral cortex
obtained from stillborn human fetuses between 24 and
28 weeks of gestation were obtained and categorized as
either IUGR (nZ7) or AGA (nZ5) (Table 1). IUGR was
defined as having i) a birth weight below the third
percentile for gestation, based on customized growth
charts, which account for maternal weight, height, parity,
ethnicity, gestation, and fetal sex (Gardosi et al. 1992) and
ii) a brain:liver weight ratio O4 (Cox & Marton 2009).
Although we had not prospectively documented the
presence of fetal growth restriction prenatally before
death, the post-mortem features were highly suggestive
of this pathology. IUGR is likely to be significant, as the
phenotype was associated with fetal demise.Immunohistochemistry
FFPE sections (5 mm) of cortical samples were immuno-
stained for MCT8 using an avidin–biotin peroxidase
technique (Vectastain Elite; all reagents from Vector
Laboratories (Peterborough, UK) unless otherwise stated)
as per the kit instructions as described previously (Chan
et al. 2011). Briefly, after dewaxing and serial rehydration,
the sections were incubated in 10 mM sodium citrate buffer
(pH 6.0) in a 95 8C water bath for 10 min. After washing in
50 mM Tris/0.15 M saline (pH 7.5; TBS), the sections were
blocked with 10% normal goat serum (Sigma–Aldrich) in
diluting buffer (TBS, 0.3% Tween 20, and 2% BSA) for
20 min. Then, consecutive sections were incubated over-
night at 4 8C with rabbit anti-MCT8 (4790) (Sigma–
Genosys Ltd., Haverhill, UK; Vasilopoulou et al. 2010,
Chan et al. 2011) at a concentration of 1 mg/ml, anti-glial
fibrillary acidic protein (GFAP, glia marker; Dako M0761 at
1:120 (Carpinteria, CA, USA)), or anti-CD68 (microglia
marker; Dako M0876 at 1:100). The sections were incu-
bated with biotinylated goat anti-rabbit secondary
antibody at 1:200 for 30 min followed by incubation in
5% HRP for 5 min and then in the avidin–biotin–
peroxidase complex for 30 min. Immunoreactivity was
visualized with 3,3 0-diaminobenzidine (15 min). All the
steps were separated by TBS–Tween washes. Sections used
for localization studies were lightly counterstained with
Mayer’s hematoxylin and mounted in Vectamount. Slides
for comparisons of IUGR fetuses with AGA fetuses were
mounted with aqueous Vectashield H1000 without coun-
terstaining. The sections were examined using bright-field
microscopy using a Zeiss microscope, and images were
captured using the AxioVision Software (Oberkochen,http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Printed in Great BritainGermany). The specificity of this MCT8 antiserum (4790)
has been determined previously (Vasilopoulou et al. 2010,
Chan et al. 2011) and confirmed in the studies by pre-
incubating the primary antibody with blocking peptide
(25 mg/ml) before application to adjacent sections.
Negative control immunostaining was also performed for
each tissue sample by omitting the primary antibody.Quantification of MCT8 immunostaining
Comparisons of IUGR fetuses with AGA fetuses focused on
the occipital cerebral cortex, which is involved in visual
perception and interpretation. The in utero development
of this structure is thought to be TH responsive (Zoeller &
Rovet 2004) and affected in IUGR (Dowdeswell et al. 1995).
We quantified i) the percentage area of cortical plate
immunostained for MCT8 and ii) the proportion of
microvessels stained for MCT8 in the subplate, with the
researcher blinded to the experimental grouping.
MCT8 staining in the cortical plate For each fetus,
five images (20! magnification) from the MCT8-
immunostained section and five corresponding images
from the adjacent section processed with the omission of
the primary antibody as a negative control were analyzed.
An objective measure of the area containing brown pixels
corresponding to immunoreactive staining for MCT8 was
quantified using the software ImageJ (U. S. National
Institutes of Health, Bethesda, MD, USA) as described
previously (Ferreira & Rasband 2012). Briefly, bright-field
images were converted to grayscale ‘RGB stack’, and the
green channel image was used for analysis. A grayscale
cutoff point derived from the corresponding negative
controls was set as the threshold signifying positive
staining and the same threshold applied to the immuno-
stained sections for each fetus. The total area of tissue
stained above the threshold was quantified and expressed
as a proportion of the total tissue area examined. The area
fraction of background noise, as determined by applying
the same threshold to the corresponding negative control,
was subtracted from the area fraction of tissue stained to
give the true proportion of area of tissue staining positively
for MCT8. Since the area of staining could also be affected
by cell density, the number of cell bodies (nuclei) within a
250!250 pixel field in each quadrant of every image
analyzed was counted and averaged to determine the
relative cellularity, which was used to correct the area
stained for MCT8. The corrected percentage of area stained
for each fetus was then expressed relative to the mean of
the AGA group, which was assigned an arbitrary value of 1.Published by Bioscientifica Ltd
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Research S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 89MCT8 staining inmicrovessels MCT8 immunoreac-
tivity in microvessels was assessed in the subplate zone, a
layer deep to the cortical plate with a lower density of cells,
where it was easily possible to identify all the microvessels
in bright field based on morphology at 40! magni-
fication. For each fetus, 20 non-overlapping images of the
subplate were taken. The number of immunostained
microvessels was counted and calculated as a percentage
of all the microvessels present. An average of 40.4G1.9
microvessels was counted per fetus. Non-specific staining
of intravascular erythrocytes was disregarded. The percen-
tage of microvessels stained was then expressed relative to
the mean of the AGA group, which was assigned an
arbitrary value of 1.
Statistical analyses
Data were analyzed using the SigmaStat Software, v3.1 (San
Jose, CA, USA). Demographic data were analyzed using the
unpaired Student’s t-test to compare continuous variables
and the Fisher’s exact test to compare contingency tables.
Quantitative data expressed as relative values were used for
analysis using the two-way ANOVA followed by the Holm–
Sidak all pairwise multiple comparisons post hoc analysis.
The quantitative datasets passed the normality and equal
variance tests. Spearman’s rank correlation test was used to
determine significant correlations between the variables.
Significance was taken as P!0.05.Results
MCT8 immunolocalization within human fetal and
adult cerebral cortex
The developing human fetal cerebral cortex in mid-
gestation is formed by several layers; from superficial to
deep, they are the marginal zone, cortical plate, subplate,
intermediate zone, subventricular zone, and ventricular
zone (lying adjacent to the ventricle; Bystron et al. 2008). At
19 weeks of gestation, sections of the parietal and occipital
cortex obtained from AGA fetuses demonstrated MCT8
immunostaining in all the layers. Immunostaining was
found within the marginal zone, in cortical plate neurons,
a proportion of cells in the subplate zone, in hippocampal
neurons, epithelial cells of the choroid plexus and
ependyma, and in numerous cells in the ventricular and
subventricular zones (Fig. 1A, B, C, D and H). A similar
distribution of MCT8 immunostaining was observed in
sections obtained from AGA fetuses at 26–37 weeks of
gestation. However, with advancing gestation andhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Printed in Great Britainmaturity of the cortex, there were fewer cells in the
ventricular and subventricular zones and, hence,
correspondingly less MCT8 staining in these layers (Fig. 1D,
EandF).Mostmicrovessels throughout theareas studiedwere
MCT8 positive (Fig. 1G). The absorption of the antibody with
the blocking peptide effectively abolished MCT8 staining,
confirming the specificity of staining (Fig. 1A, B and C).
MCT8 immunostaining corresponded with the well-
described pattern of neuronal cell distribution within the
cerebral cortex, with the greatest staining being observed in
the cortical plate, which is dense with neurons. Neuronal
localization of MCT8 was also supported by our findings
that immunostaining for GFAP and CD68, indicating glia
and microglia respectively, in adjacent sections revealed an
entirely different pattern of distribution in all the layers of
the cortex (Fig. 1J and K) compared with immunostaining
for MCT8. Specifically, there was no GFAP (Fig. 1L) or
CD68 immunostaining in the cortical plate. In addition,
the morphology of cells stained with each antibody was
clearly different. Neurons were identified by a round dense
nucleus and abundant cytoplasm with dendritic branches,
many of which were immunostained for MCT8, in contrast
to astrocytes, which had a large irregular nucleus with clear
nucleoplasm containing a vesicular chromatin pattern and
very small or absent nucleoli showing no MCT8 immuno-
staining (Fig. 1H and I). Within the subplate only a selected
population of neurons were MCT8 positive at every
gestational age examined. In the adult occipital cortex,
microvessels were immunostained for MCT8, but propor-
tionally fewer neurons were immunostained for MCT8
compared with those in the fetal cortex (data not shown).Comparison of MCT8 immunostaining in the occipital
cortex of AGA and IUGR fetuses
There were no significant differences between the IUGR
and AGA cohorts in terms of gestational age and fetal sex
(Table 1). Compared with the AGA group, the IUGR group
had significantly lower raw birth weights (P!0.05; with all
the customized birth weight percentiles being under the
third percentile), but the raw brain weights were not
significantly different between the two groups, with brain
weights being well preserved for gestation even in the IUGR
cohort (1.08 relative to the expected mean). However, the
relative brain weights (ratio to the expected mean for
gestation) in the IUGR group were still lower compared
with those in the AGA group (P!0.05). The brain:liver
weight ratios in the IUGR group were significantly higher
compared with those in the AGA group (P!0.01). Atrophy
of the thymus secondary to chronic stress in IUGR (Cox &Published by Bioscientifica Ltd
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Figure 1
MCT8 immunohistochemistry of cerebral cortex sections obtained from
structurally normal fetuses with unexplained intrauterine death. Corres-
ponding negative controls (antibody absorption by the blocking peptide)
of adjacent sections are shown in panel inserts in the bottom right corner
for (A, B and C). At 19 weeks, MCT8 was located in the cortical plate within
the parietal cortex (PC) with less staining in the marginal zone (MZ) (A),
in the choroid plexus (CP) (B), and the hippocampus (C). MCT8 immuno-
staining was also observed in the ependymal cells lining the ventricle (V)
and in numerous cells within the ventricular zone (VZ) and subventricular
zone (SVZ) at 19 weeks (D), 26 weeks (E), and 37 weeks (F). MCT8
immunostaining was observed in the wall of a microvessel in the subplate
at 19 weeks (G) and in neurons in the intermediate zone at 19 weeks (H)
and 37 weeks (I; arrow points to a neuron). An adjacent section stained
with GFAP is shown in a panel insert in the bottom right corner for (H)
showing differences in the morphology of immunostained cells. At
19 weeks, CD68 immunostaining for microglia (J) and GFAP immuno-
staining for glia (K) in the ventricular and subventricular zones showed a
different pattern of staining compared to that of MCT8. There was also a
lack of GFAP staining in the cortical plate and marginal zone of the parietal
cortex at 19 weeks (L). Magnification barZ50 mm.
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Research S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 90Marton 2009) was also evident by the significantly reduced
raw thymus weights (P!0.01) and thymus weights relative
to the expected mean for gestation (P!0.001). All these
indicate that the IUGR cohort comprised cases at the severehttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Printed in Great Britainend of the spectrum. Most of the IUGR cases demonstrated
features of chronic uteroplacental failure on placental
examination (Table 1; ReCoDe C4 and C5), which were
absent in the AGA cohort.Published by Bioscientifica Ltd
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Figure 2
Quantification of MCT8 immunostaining in the occipital cerebral cortex of
intrauterine growth-restricted (IUGR) fetuses (nZ7; black bars) compared
with that in the occipital cerebral cortex of appropriately grown for
gestational age (AGA) fetuses (nZ5; white bars). The percentage area of
cortical plate and the proportion of microvessels in the subplate
immunostained for MCT8 are expressed relative to the mean of the AGA
group, which was given an arbitrary value of 1. Columns and error bars
represent the mean and S.E.M. Statistically significant difference, *P!0.05.
Figure 3
Representative sections showing MCT8 immunostaining of the cortical
plate of an intrauterine growth-restricted (IUGR) fetus (A) and an
appropriately grown for gestational age (AGA) fetus (B) within the
occipital cerebral cortex. Corresponding negative controls (no primary
antibody) of adjacent sections are shown in a panel insert in the bottom
right corner. An example of a positively MCT8-immunostained microvessel
in the subplate (C) compared with a negative one (shown in a panel insert
in the bottom right corner) from the same section immunostained for
MCT8 is shown.
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Research S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 91The overall two-way ANOVA, which analyzed the
entire dataset, indicated significantly reduced MCT8
expression in the occipital cortex of IUGR fetuses
compared with that in AGA fetuses (P!0.05). However,
post hoc tests indicated that the difference was significant
only for cortical plate immunostaining (P!0.05; Fig. 2).
The mean percentage area of cortical plate immuno-
staining after correction for relative cell number was
4.7G1.5% (meanGS.E.M.; 0.2G0.07 relative to AGA) in the
IUGR group compared with 23.3G8.1% (1G0.3 relative to
AGA) in the AGA group (P!0.05), which represents
approximately a fivefold decrease in MCT8 expression
with IUGR (Fig. 2). The cellularity within the cortical plate
was not significantly different between the two cohorts
(IUGR, 1.3G0.1 and AGA, 1G0.1). General observations
of cortical plate images indicated that the decrease
in MCT8 staining was confined to morphologically
defined neuronal cells, while microvessels seemed to be
spared (Fig. 3).
Post hoc tests revealed no statistically significant
difference in the proportion of microvessels stained for
MCT8 in the IUGR samples (27.9G10.0%; 0.6G0.2
relative to AGA) compared with that in the AGA samples
(45.2G9.6%; 1G0.2 relative to AGA; Fig. 2).
However, there was a significant positive correlation
between the area of cortical plate MCT8 immunostaining
and the proportion of microvessels stained in the subplate
(correlation coefficientZ0.71, r2Z0.27; P!0.01) when allhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
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Printed in Great Britain
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Figure 4
(A) Correlation between the relative cortical plate area immunostained for
MCT8 and the relative proportion of microvessels immunostained for MCT8
in IUGR (black dots) and AGA (white squares) fetuses. A significant positive
correlation was observed when all the samples were considered together
(dashed line) and when only the IUGR samples were considered on their
own (straight line), but there was no significant correlation when only
among the AGA samples were considered on their own (dashed and dotted
line). (B) Correlation between the relative cortical plate area immunos-
tained for MCT8 and the brain:liver weight ratio. A negative correlation
was observed when all the samples were considered together. Statistically
significant differences are **P!0.01, *P!0.05.
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Research S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 92the samples were analyzed together. The positive corre-
lation remained significant within the IUGR group
(correlation coefficientZ0.75, r2Z0.12; P!0.05; Fig. 4A),
but there was no significant correlation within the AGA
cohort on its own.
When all the samples were analyzed together, a
negative correlation was also observed between the area
of cortical plate MCT8 immunostaining and brain:liver
weight ratios (correlation coefficientZK0.64, r2Z0.28;
P!0.05; Fig. 4B). There was no correlation between
MCT8 immunostaining in the cortical plate or
microvessels with either gestational age or fetal sex.Discussion
Changes in TH transporter expression have never been
described in the growth-restricted state. This study is thehttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Printed in Great Britainfirst to demonstrate significantly reduced cortical MCT8
expression within the developing CNS of human fetuses
stillborn with severe IUGR. Our results suggest that altered
TH transporter activity in cerebral neurons could be a
contributory factor to the pathophysiology of neurodeve-
lopmental impairment associated with IUGR.
The strength of this study is the use of human fetal
tissue samples, thus eliminating species differences,
particularly relevant, as Mct8-knockout mice lack the
neurological phenotype observed in humans with MCT8
mutations. However, a limitation is the restriction of the
availability of human fetal tissue samples of adequate
quality for investigation, hence, the small number of
samples in this study.
The localization of MCT8 in developing neurons
across the different cortical layers, microvessels, and
choroid plexus reported herein is generally consistent
with the findings of previously published studies of
human fetuses (Roberts et al. 2008, Wirth et al. 2009)
and supports its role in the uptake of TH into the brain
parenchyma from the blood and cerebrospinal fluid, as
well as into neurons, from early fetal development.
Neurogenesis takes place in the ventricular and
subventricular zones with much being completed by 28
weeks of gestation (Bystron et al. 2008). MCT8 staining in
these neuroprecursor-rich areas at 19–26 weeks suggests its
involvement in the regulation of neurogenesis. Indeed, we
have previously demonstrated that MCT8 represses the
proliferation of the human neuronal precursor cell NT2 in
a T3-independent manner (James et al. 2009); however,
MCT8 had no effect on NT2 neurodifferentiation in vitro
(Chan et al. 2011). Post-mitotic neurons migrate away
from the proliferative zones and, by 24–28 weeks of
gestation, most cortical neurons have settled to form the
cortical plate, an area comprising predominantly neuronal
cells (Bystron et al. 2008).
During normal human fetal cortical development,
over 70% of neurons undergo programmed cell death after
32 weeks of gestation (Rabinowicz et al. 1996). Magnetic
resonance imaging (MRI) assessments of IUGR premature
infants at 33–34 weeks have shown reduced cerebral
cortical gray matter volume (Tolsa et al. 2004), which
could be due to reduced cell numbers in the cortical plate
(Samuelsen et al. 2003). Similar to that observed in our
IUGR cohort at 24–28 weeks, that study (Samuelsen et al.
2003), however, found no significant differences in
cortical cell numbers compared with AGA samples before
27 weeks.
MCT8 promotes cell death in non-proliferative
cytotrophoblast cells from human placentaPublished by Bioscientifica Ltd
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Research S Y CHAN and others MCT8 in IUGR human fetal brain 220 :2 93independently of T3 (Vasilopoulou et al. 2013). It remains
speculative whether MCT8 could also have a similar
effect on neuronal apoptosis. If so, the down-
regulation of MCT8 expression in IUGR neurons could
be a protective mechanism to limit neuronal apoptosis at
the expense of TH transport, of which the latter could be
partially compensated for by other TH transporters
expressed by neurons, as we and others have previously
described in the human fetal cerebral cortex (Wirth et al.
2009, Chan et al. 2011).
Whether the reduction in cortical cell number in the
third trimester is due to reduced neurogenesis, reduced
neuronal migration, or increased cell death in IUGR is not
known. In rats, abnormal neuronal migration in the fetal
CNS in both IUGR (Sasaki et al. 2000) and TH deficiency
(Auso et al. 2004) has been reported. Maternal TH
deficiency in rats has also been reported to lead to
impaired neurogenesis and diminished neocortical
neuronal numbers (Mohan et al. 2012). The extent to
which these altered cellular processes in IUGR, as well as
possibly altered synaptogenesis and dendritic branching,
are mediated by diminished TH action secondary to
reductions in circulating TH concentrations, MCT8
transport, and TR expression remains the subject of
investigation. Other factors such as cerebral hypoxia and
prematurity are also likely to contribute to this neuro-
pathology. Whatever the etiologies, alterations in brain
neural networks assessed by MRI in IUGR infants have
been found to be associated with later neurodevelop-
mental outcomes (Batalle et al. 2012).
Current understanding of the physiological regulation
of MCT8 expression is poor. TH status has been shown to
influence MCT8 expression in some tissues (Capelo et al.
2009) but not in others (Mebis et al. 2009). In IUGR, MCT8
expression in the human placenta is upregulated
(Vasilopoulou et al. 2010) in contrast to that in the fetal
cerebral cortex. These tissue-specific effects argue against a
general alteration in MCT8 activity being part of the
etiology of IUGR, but rather suggest that altered cerebral
MCT8 expression is a local adaptive response to the
growth-restricted state that is associated with chronic
distress, which is supported by our finding that the greater
the growth restriction, the lower the MCT8 expression.
This is in contrast to the AGA fetuses that presumably
suffered from an acute event just before death. The
positive correlation between MCT8 expression in the
cortical plate and that in microvessels suggests that there
may be some common mechanisms regulating MCT8
expression in the CNS.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0400
 2014 The authors
Printed in Great BritainFuture studies should investigate whether there are
compensatory alterations in the expression of other TH
transporters in neurons and microvessels. Studies could
also extend to other regions of the CNS and at
different gestational ages to obtain a more comprehensive
picture of the effects of IUGR on TH transport and how
this could correlate with observed neurological impair-
ments in IUGR survivors.
In conclusion, our results showing perturbed patterns
of cortical MCT8 expression support the hypothesis
that a reduction in MCT8 expression in the IUGR fetal
CNS could be a contributory factor implicated in the
long-term neurodevelopmental impairments associated
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